[go: up one dir, main page]

GB0008801D0 - Sequences - Google Patents

Sequences

Info

Publication number
GB0008801D0
GB0008801D0 GBGB0008801.3A GB0008801A GB0008801D0 GB 0008801 D0 GB0008801 D0 GB 0008801D0 GB 0008801 A GB0008801 A GB 0008801A GB 0008801 D0 GB0008801 D0 GB 0008801D0
Authority
GB
United Kingdom
Prior art keywords
sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0008801.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Priority to GBGB0008801.3A priority Critical patent/GB0008801D0/en
Publication of GB0008801D0 publication Critical patent/GB0008801D0/en
Priority to PCT/GB2001/001622 priority patent/WO2001077380A2/en
Priority to AU2001244421A priority patent/AU2001244421A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB0008801.3A 2000-04-10 2000-04-10 Sequences Ceased GB0008801D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0008801.3A GB0008801D0 (en) 2000-04-10 2000-04-10 Sequences
PCT/GB2001/001622 WO2001077380A2 (en) 2000-04-10 2001-04-10 Method for predicting predisposition to a disease associated with mutations in a rpgr gene
AU2001244421A AU2001244421A1 (en) 2000-04-10 2001-04-10 Method for predicting predisposition to a disease associated with mutations in a rpgr gene

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0008801.3A GB0008801D0 (en) 2000-04-10 2000-04-10 Sequences

Publications (1)

Publication Number Publication Date
GB0008801D0 true GB0008801D0 (en) 2000-05-31

Family

ID=9889600

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0008801.3A Ceased GB0008801D0 (en) 2000-04-10 2000-04-10 Sequences

Country Status (3)

Country Link
AU (1) AU2001244421A1 (en)
GB (1) GB0008801D0 (en)
WO (1) WO2001077380A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10836803B2 (en) 2015-09-10 2020-11-17 Oxford University Innovation Limited Treatment of retinitis pigmentosa

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2950876A1 (en) 2014-06-10 2015-12-17 Erasmus University Medical Center Rotterdam Methods for characterizing alternatively or aberrantly spliced mrna isoforms
GB201412011D0 (en) * 2014-07-04 2014-08-20 Ucl Business Plc Treatments
DK3821912T3 (en) * 2014-07-24 2024-08-05 Massachusetts Eye & Ear Infirmary RPGR gene therapy for retinitis pigmentosa
CN106987637B (en) * 2017-04-25 2020-06-02 郑州大学第一附属医院 Amplification primer, kit and application for detecting familial retinitis pigmentosa pathogenic gene mutation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10836803B2 (en) 2015-09-10 2020-11-17 Oxford University Innovation Limited Treatment of retinitis pigmentosa

Also Published As

Publication number Publication date
WO2001077380A3 (en) 2002-09-06
WO2001077380A2 (en) 2001-10-18
AU2001244421A1 (en) 2001-10-23

Similar Documents

Publication Publication Date Title
GB0015923D0 (en) Methods
GB0011459D0 (en) Sequences
GB0028849D0 (en) Improved keysheath
GB0008801D0 (en) Sequences
GB0026094D0 (en) Methods
GB0031744D0 (en) Methods
GB0126164D0 (en) Sequences
GB0001005D0 (en) Methods
GB0031390D0 (en) Methods
GB0111194D0 (en) Sequences
GB0007989D0 (en) Methods
GB0021859D0 (en) Methods
GB0102454D0 (en) Methods
GB0024510D0 (en) Methods
GB0004254D0 (en) Improved capodastro
GB2364426B (en) Improved capodastro
GB0008903D0 (en) Stage-specific sequences
GB0000992D0 (en) Methods
GB0126397D0 (en) Sequences
GB0126165D0 (en) Sequences
GB0126163D0 (en) Sequences
GB0125498D0 (en) Sequences
AU2117P (en) Gauka Gaura lindheimeri
GB0005838D0 (en) Sequence
GB0005848D0 (en) Sequence

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)